Napo Pharm.Regs Share Discussion Threads

[monis] 07/5/2008 15:49

News out on share awards.

[monis] 07/5/2008 13:00

It will be interesting to see if anyone from the company bought the 300,000 yesterday.

[double6] 07/5/2008 12:57

Whay re they still buying such small amounts though ??

[monis] 07/5/2008 12:55

Another buy from a Doctor associated with the company has just been reported.

[monis] 06/5/2008 17:12

Anyone interested at seeing the potential upside to this company should take a look at the annual report and accounts and look under the 'Market' heading. The upside for the HIV drug if phase 3 is completed and of cause succesful is huge.

Of cause do your own research.

[monis] 06/5/2008 15:52

I would expect to see a large delayed buy appear anytime now.

[monis] 06/5/2008 15:43

Also these have been going up with relatively small buys until the 300,000 today. When the big buys come in these could rise very quickly.

[monis] 06/5/2008 15:35

From recent update. Make of it what you will.


...Management have plans to raise additional funds, which include: the out-license of certain rights to crofelemer including the indications of CRO-HIV, CRO-IBS,CRO-ID and CRO-PED in the United States and other western territories; as well as certain rights to NP-500, in exchange for a licensing fee(s)...


...Sir William Young, Chairman of the Board of Napo commented: "While Napo needs to bring in funds from corporate partnering and other activities in order to complete its Phase 3 trial, the board feels the recent stock price drop dramatically undervalues the company."

... Lisa A. Conte CEO of Napo Pharmaceuticals, Inc. commented:

"It is my firm belief that, the fall in the Company's share price places an
unrealistic value on Napo and disregards the recently announced trial results.



Of cause DYOR.

[monis] 06/5/2008 15:30

I bought in a few weeks ago and they have been going up 10-20% every day! I just think they dropped on very few trades and the news they have been putting out is good. Phase 3 HIV drug in America.

[katsy] 06/5/2008 15:23

Monis, you talking to yourself again? remember to take that medication. I remember you ramping these a few days ago, looks like you've finally hit a good one, unlike HML. Anyway good luck.

[monis] 06/5/2008 15:08

Up 40% now, must be a large delayed buy yet to be reported imo.

[monis] 06/5/2008 13:15

It will be interesting if the 300,000 buyer this morning is already a holder. News in the next few days I suppose if they are and have over 3%.

[monis] 06/5/2008 10:11

Just one 10,000 buy has moved L2 to 2v1. Looking very good. WINS now want 8p.

[monis] 06/5/2008 09:43

2 150,000 buys this morning. This could potentially move up very quickly now.

[monis] 01/5/2008 14:38

Anyone interested at seeing the potential upside to this company should take a look at the annual report and accounts and look under the 'Market' heading. The upside for the HIV drug if phase 3 is completed and of cause succesful is potentially huge.

Of cause do your own research.

[monis] 01/5/2008 11:43

Up another 20% with the annual report and accounts.

[monis] 30/4/2008 15:12

Another buy of 80,000 reported.

[monis] 30/4/2008 13:15

100,000 buy reported.

[monis] 30/4/2008 10:35

L2 2v1. Interesting to see if there are more buys today after 2pm.

[monis] 29/4/2008 17:12

I would hazzard a guess that they are more director buys. Around 2pm is when those in the US would start buying.

[monis] 29/4/2008 16:13

From recent update. Make of it what you will.


...Management have plans to raise additional funds, which include: the out-license of certain rights to crofelemer including the indications of CRO-HIV, CRO-IBS,CRO-ID and CRO-PED in the United States and other western territories; as well as certain rights to NP-500, in exchange for a licensing fee(s)...


...Sir William Young, Chairman of the Board of Napo commented: "While Napo needs to bring in funds from corporate partnering and other activities in order to complete its Phase 3 trial, the board feels the recent stock price drop dramatically undervalues the company."

... Lisa A. Conte CEO of Napo Pharmaceuticals, Inc. commented:

"It is my firm belief that, the fall in the Company's share price places an
unrealistic value on Napo and disregards the recently announced trial results.



Of cause DYOR.

[monis] 29/4/2008 15:32

L2 looks poised for another tick up. 2v1. Both mm's are now on 4p bid while they are offering at 6 and 7p.

[monis] 29/4/2008 15:29

Could well be the directors buying again. Should soon know.

[monis] 29/4/2008 15:25

2 more 50,000 buys.

[monis] 28/4/2008 14:42

50,000 at 4.5p reported. I would guess that is a buy from friday. Could be another director buy. Should find out later today or Tuesday.